Humana (HUM) Other Accumulated Expenses (2009 - 2026)

Humana (HUM) has reported Other Accumulated Expenses for 18 consecutive years, with $12.9 billion the latest figure, recorded in Q2 2026.

• In Q2 2026, Other Accumulated Expenses rose 16.42% year-over-year to $12.9 billion; the TTM figure through Jun 2026 stood at $12.9 billion (up 16.42% YoY), while the FY2025 annual figure was $10.0 billion, down 4.53% from the prior year.
• Other Accumulated Expenses climbed to $12.9 billion in Q2 2026 per HUM's latest filing, from $12.7 billion in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $12.9 billion in Q2 2026 and bottomed at $9.2 billion in Q3 2022.
• Historically, Other Accumulated Expenses has averaged $10.6 billion across 5 years, with a median of $10.3 billion in 2023.
• Annual changes were most pronounced in 2024 — Other Accumulated Expenses rose 17.08% — and 2025, when it decreased 9.32%.
• Humana's Other Accumulated Expenses stood at $9.3 billion in 2022, then advanced by 10.55% to $10.2 billion in 2023, then climbed by 1.94% to $10.4 billion in 2024, then decreased by 4.53% to $10.0 billion in 2025, then advanced by 29.19% to $12.9 billion in 2026.
• Business Quant data shows HUM's Other Accumulated Expenses at $12.9 billion in Q2 2026, $12.7 billion in Q1 2026, and $10.0 billion in Q4 2025.